BNTC News and Press, Benitec Biopharma Limited From 02/24/21

Benitec Biopharma (BNTC) announces results of the interim analysis of the BB-301 Pilot Dosing Study for the treatment of Oculopharyngeal Muscular Dystrophy ((OPMD)), a chronic, life-threatening genetic disorder.Shares of the company up nearly 6% premarket.Patients with OPMD los...

Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study PR Newswire HAYWARD, Calif. , Feb. 24, 2021 /PRNewswire/ -- Highlights from the Interim Analysis: Biologically significant, hig...

Benitec Biopharma Announces 2020 Annual Stockholder Meeting HAYWARD, Calif. , Dec. 7, 2020 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), today announced that its 2020 Annual Meeting of Stockholders will be held virtually on Wednesday December 9, 2020 at 3...

Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares PR Newswire HAYWARD, Calif., Oct. 6, 2020 HAYWARD, Calif. , Oct. 6, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (...

MyoKardia (MYOK) +59% as Bristol to acquire the company for $225/Share.Kosmos Energy (KOS) +50% as company closed a Gulf of Mexico facility with Beal Bank USA and Trafigura Trading LLC.Enlivex Therapeutics (ENLV) +49%.Corvus Pharmaceuticals (CRVS) +38% on co-foun...

Gainers: American Renal Associates (ARA) +68%.IDT (IDT) +37%.Nano-X Imaging (NNOX) +36%.Westwater Resources (WWR) +24%.voxeljet (VJET) +21%.Houghton Mifflin Harcourt (HMHC) +21%.ProPhase Labs (PRPH) +19%.Lithium Americas (LAC) +19%.Telenav (TNAV) +18%.Assured Guaranty (AGO) +17...

Gainers: Aduro Biotech (ADRO) +442%, American Renal Associates (ARA) +69%, Nano-X Imaging (NNOX) +38%, CTI BioPharma (CTIC) +18%, ProPhase Labs (PRPH) +16%.Losers: Benitec Biopharma (BNTC) -36%, Mesoblast (MESO) -36%, Arcutis Biotherapeut...

Benitec Biopharma (BNTC) prices an underwritten public offering of ~3.23M shares of its common stock at a price of $3.10/share for an aggregate gross proceeds of ~$10M.Underwriters have an option to purchase up to 483.9k additional shares.Net proceeds from the offering will be ...

Benitec Biopharma Announces Pricing of $10.0 Million Public Offering PR Newswire HAYWARD, Calif., Oct. 2, 2020 HAYWARD, Calif. , Oct. 2, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene the...

Mesoblast (MESO) -37% after FDA rejects cell therapy application for treatment-resistant graft-vs-host disease.Benitec Biopharma (BNTC) -26%.Greenpro Capital (GRNQ) -18%.Tuniu (TOUR) -14%.Hall of Fame Resort & Entertainment (HOFV) -13%.Iterum Therapeutics (ITRM) -12%.Oxbridge Re...